Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
GEN
31m
Asimov and RevOpsis Therapeutics Ink Licensing Deal for Multispecific-Expressing Cell Line
RevOpsis says it is committed to the rapid discovery and development of novel multispecific therapies utilizing its modular ...
GEN
34m
Abzena Expands Analytical Capabilities to Include GMP Cell-Based Potency Testing
Abzena's goal is to help customers optimize drug development strategies, secure funding, and navigate regulatory pathways more effectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
To lead Medicare, Medicaid
Commerce secretary pick
Bulls legend dies at 81
Seeks Capitol bathroom ban
22 trapped for 2 hours
UKR fires US-made missiles
Debris falls from roof
Crash ratings get update
Tbilisi protest camp raided
Rookie of the Year winners
Clemency decision delayed
Microsoft pitches AI 'agents'
Labor agency dispute
NBA YoungBoy pleads guilty
Recommended content reset
NYC issues drought warning
Launches bid to lead DNC
Victims sue Colorado county
Jeffries wins reelection
Updates nuclear doctrine
2nd-oldest US resident dies
Hush money case delayed
Subway chokehold trial
Attorney for accusers sued
FEMA faces tough questions
Travel guide innovator dies
Driver's bias verdict reduced
Hacker accessed Gaetz file?
WY abortion laws rejected
NYC congestion pricing plan
Feedback